300149 睿智醫藥
按盤價 
12.950 -0.250 (-1.894%)
12.950 -0.250 (-1.894%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.070 | -17.089 | -48.477 | 16.827 | -18.316 |
| 總資產報酬率 ROA (%) | 1.277 | -10.224 | -29.372 | 9.037 | -9.647 |
| 投入資產回報率 ROIC (%) | 1.437 | -11.502 | -32.939 | 10.070 | -10.735 | 邊際利潤分析 |
| 銷售毛利率 (%) | 29.014 | 21.800 | 25.935 | 25.423 | 31.690 |
| 營業利潤率 (%) | 5.933 | -22.350 | -82.255 | 56.350 | -21.021 |
| 息稅前利潤/營業總收入 (%) | 6.188 | -23.476 | -81.322 | 55.826 | -16.483 |
| 淨利潤/營業總收入 (%) | 4.748 | -23.347 | -80.549 | 27.320 | -23.783 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 63.047 | 26.521 | 6.392 | -11.315 | 2.377 |
| 價值變動淨收益/利潤總額(%) | 40.106 | -3.365 | 0.098 | 190.871 | -3.061 |
| 營業外收支淨額/利潤總額(%) | 1.368 | 6.392 | 0.362 | -2.575 | 1.559 | 償債能力分析 |
| 流動比率 (X) | 1.981 | 1.858 | 1.704 | 1.749 | 0.694 |
| 速動比率 (X) | 1.940 | 1.825 | 1.639 | 1.691 | 0.625 |
| 資產負債率 (%) | 36.267 | 37.967 | 39.988 | 37.762 | 52.839 |
| 帶息債務/全部投入資本 (%) | 10.122 | 10.546 | 10.329 | 15.544 | 31.887 |
| 股東權益/帶息債務 (%) | 695.813 | 648.516 | 643.036 | 443.387 | 162.182 |
| 股東權益/負債合計 (%) | 172.366 | 160.194 | 147.585 | 163.121 | 88.150 |
| 利息保障倍數 (X) | 35.919 | -58.773 | -66.008 | 62.684 | -3.384 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 60.961 | 81.738 | 95.718 | 91.814 | 76.617 |
| 存貨周轉天數 (天) | 6.065 | 9.329 | 15.094 | 20.310 | 19.267 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
